nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoflurane—Hyperkalaemia—Fludarabine—lymphatic system cancer	0.0368	0.0368	CcSEcCtD
Isoflurane—Hepatic function abnormal—Teniposide—lymphatic system cancer	0.0354	0.0354	CcSEcCtD
Isoflurane—Ileus—Vincristine—lymphatic system cancer	0.0324	0.0324	CcSEcCtD
Isoflurane—Jaundice—Mechlorethamine—lymphatic system cancer	0.0315	0.0315	CcSEcCtD
Isoflurane—Necrosis—Carmustine—lymphatic system cancer	0.0306	0.0306	CcSEcCtD
Isoflurane—Hepatic failure—Fludarabine—lymphatic system cancer	0.0303	0.0303	CcSEcCtD
Isoflurane—Necrosis—Mitoxantrone—lymphatic system cancer	0.0284	0.0284	CcSEcCtD
Isoflurane—Bronchospasm—Teniposide—lymphatic system cancer	0.0263	0.0263	CcSEcCtD
Isoflurane—Hyperkalaemia—Mitoxantrone—lymphatic system cancer	0.0219	0.0219	CcSEcCtD
Isoflurane—Hyperglycaemia—Fludarabine—lymphatic system cancer	0.0212	0.0212	CcSEcCtD
Isoflurane—Chills—Teniposide—lymphatic system cancer	0.0192	0.0192	CcSEcCtD
Isoflurane—Arrhythmia—Teniposide—lymphatic system cancer	0.0191	0.0191	CcSEcCtD
Isoflurane—Hepatic failure—Vincristine—lymphatic system cancer	0.0185	0.0185	CcSEcCtD
Isoflurane—Agitation—Teniposide—lymphatic system cancer	0.0171	0.0171	CcSEcCtD
Isoflurane—Bronchospasm—Bleomycin—lymphatic system cancer	0.017	0.017	CcSEcCtD
Isoflurane—Chills—Fludarabine—lymphatic system cancer	0.0169	0.0169	CcSEcCtD
Isoflurane—Arrhythmia—Fludarabine—lymphatic system cancer	0.0168	0.0168	CcSEcCtD
Isoflurane—Cardiac arrest—Vincristine—lymphatic system cancer	0.0158	0.0158	CcSEcCtD
Isoflurane—Agitation—Fludarabine—lymphatic system cancer	0.0151	0.0151	CcSEcCtD
Isoflurane—Cough—Fludarabine—lymphatic system cancer	0.0143	0.0143	CcSEcCtD
Isoflurane—Hypotension—Teniposide—lymphatic system cancer	0.0142	0.0142	CcSEcCtD
Isoflurane—Necrosis—Methotrexate—lymphatic system cancer	0.0142	0.0142	CcSEcCtD
Isoflurane—Hyperglycaemia—Carmustine—lymphatic system cancer	0.0136	0.0136	CcSEcCtD
Isoflurane—Vomiting—Mechlorethamine—lymphatic system cancer	0.0131	0.0131	CcSEcCtD
Isoflurane—Rash—Mechlorethamine—lymphatic system cancer	0.013	0.013	CcSEcCtD
Isoflurane—Dermatitis—Mechlorethamine—lymphatic system cancer	0.013	0.013	CcSEcCtD
Isoflurane—Hyperglycaemia—Mitoxantrone—lymphatic system cancer	0.0126	0.0126	CcSEcCtD
Isoflurane—Chills—Bleomycin—lymphatic system cancer	0.0124	0.0124	CcSEcCtD
Isoflurane—Nausea—Mechlorethamine—lymphatic system cancer	0.0123	0.0123	CcSEcCtD
Isoflurane—Jaundice—Mitoxantrone—lymphatic system cancer	0.0122	0.0122	CcSEcCtD
Isoflurane—Body temperature increased—Teniposide—lymphatic system cancer	0.012	0.012	CcSEcCtD
Isoflurane—Hallucination—Carmustine—lymphatic system cancer	0.012	0.012	CcSEcCtD
Isoflurane—Hallucination—Vincristine—lymphatic system cancer	0.0114	0.0114	CcSEcCtD
Isoflurane—Hepatitis—Mitoxantrone—lymphatic system cancer	0.0112	0.0112	CcSEcCtD
Isoflurane—Arrhythmia—Carmustine—lymphatic system cancer	0.0108	0.0108	CcSEcCtD
Isoflurane—Cardiac disorder—Vincristine—lymphatic system cancer	0.0107	0.0107	CcSEcCtD
Isoflurane—Body temperature increased—Fludarabine—lymphatic system cancer	0.0106	0.0106	CcSEcCtD
Isoflurane—Cough—Bleomycin—lymphatic system cancer	0.0105	0.0105	CcSEcCtD
Isoflurane—Chills—Mitoxantrone—lymphatic system cancer	0.0101	0.0101	CcSEcCtD
Isoflurane—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.01	0.01	CcSEcCtD
Isoflurane—Vomiting—Teniposide—lymphatic system cancer	0.00968	0.00968	CcSEcCtD
Isoflurane—Agitation—Carmustine—lymphatic system cancer	0.00964	0.00964	CcSEcCtD
Isoflurane—Rash—Teniposide—lymphatic system cancer	0.0096	0.0096	CcSEcCtD
Isoflurane—Dermatitis—Teniposide—lymphatic system cancer	0.00959	0.00959	CcSEcCtD
Isoflurane—Agitation—Vincristine—lymphatic system cancer	0.0092	0.0092	CcSEcCtD
Isoflurane—Hypotension—Bleomycin—lymphatic system cancer	0.00916	0.00916	CcSEcCtD
Isoflurane—Nausea—Teniposide—lymphatic system cancer	0.00904	0.00904	CcSEcCtD
Isoflurane—Hepatic failure—Methotrexate—lymphatic system cancer	0.00898	0.00898	CcSEcCtD
Isoflurane—Cough—Mitoxantrone—lymphatic system cancer	0.00851	0.00851	CcSEcCtD
Isoflurane—Vomiting—Fludarabine—lymphatic system cancer	0.0085	0.0085	CcSEcCtD
Isoflurane—Rash—Fludarabine—lymphatic system cancer	0.00843	0.00843	CcSEcCtD
Isoflurane—Dermatitis—Fludarabine—lymphatic system cancer	0.00843	0.00843	CcSEcCtD
Isoflurane—Hypotension—Carmustine—lymphatic system cancer	0.008	0.008	CcSEcCtD
Isoflurane—Nausea—Fludarabine—lymphatic system cancer	0.00794	0.00794	CcSEcCtD
Isoflurane—Body temperature increased—Bleomycin—lymphatic system cancer	0.00775	0.00775	CcSEcCtD
Isoflurane—Hypotension—Vincristine—lymphatic system cancer	0.00764	0.00764	CcSEcCtD
Isoflurane—Hypotension—Mitoxantrone—lymphatic system cancer	0.00744	0.00744	CcSEcCtD
Isoflurane—Body temperature increased—Carmustine—lymphatic system cancer	0.00677	0.00677	CcSEcCtD
Isoflurane—Body temperature increased—Vincristine—lymphatic system cancer	0.00646	0.00646	CcSEcCtD
Isoflurane—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00629	0.00629	CcSEcCtD
Isoflurane—Vomiting—Bleomycin—lymphatic system cancer	0.00624	0.00624	CcSEcCtD
Isoflurane—Rash—Bleomycin—lymphatic system cancer	0.00618	0.00618	CcSEcCtD
Isoflurane—Dermatitis—Bleomycin—lymphatic system cancer	0.00618	0.00618	CcSEcCtD
Isoflurane—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.00588	0.00588	CcSEcCtD
Isoflurane—Nausea—Bleomycin—lymphatic system cancer	0.00582	0.00582	CcSEcCtD
Isoflurane—Hepatitis—Methotrexate—lymphatic system cancer	0.00558	0.00558	CcSEcCtD
Isoflurane—Vomiting—Carmustine—lymphatic system cancer	0.00544	0.00544	CcSEcCtD
Isoflurane—Rash—Carmustine—lymphatic system cancer	0.0054	0.0054	CcSEcCtD
Isoflurane—Dermatitis—Carmustine—lymphatic system cancer	0.00539	0.00539	CcSEcCtD
Isoflurane—Vomiting—Vincristine—lymphatic system cancer	0.0052	0.0052	CcSEcCtD
Isoflurane—Cardiac disorder—Methotrexate—lymphatic system cancer	0.00518	0.00518	CcSEcCtD
Isoflurane—Rash—Vincristine—lymphatic system cancer	0.00515	0.00515	CcSEcCtD
Isoflurane—Dermatitis—Vincristine—lymphatic system cancer	0.00515	0.00515	CcSEcCtD
Isoflurane—Nausea—Carmustine—lymphatic system cancer	0.00508	0.00508	CcSEcCtD
Isoflurane—Vomiting—Mitoxantrone—lymphatic system cancer	0.00506	0.00506	CcSEcCtD
Isoflurane—Rash—Mitoxantrone—lymphatic system cancer	0.00502	0.00502	CcSEcCtD
Isoflurane—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00501	0.00501	CcSEcCtD
Isoflurane—Chills—Methotrexate—lymphatic system cancer	0.00501	0.00501	CcSEcCtD
Isoflurane—Nausea—Vincristine—lymphatic system cancer	0.00485	0.00485	CcSEcCtD
Isoflurane—Nausea—Mitoxantrone—lymphatic system cancer	0.00473	0.00473	CcSEcCtD
Isoflurane—Cough—Methotrexate—lymphatic system cancer	0.00424	0.00424	CcSEcCtD
Isoflurane—Hypotension—Methotrexate—lymphatic system cancer	0.0037	0.0037	CcSEcCtD
Isoflurane—Body temperature increased—Methotrexate—lymphatic system cancer	0.00313	0.00313	CcSEcCtD
Isoflurane—Vomiting—Methotrexate—lymphatic system cancer	0.00252	0.00252	CcSEcCtD
Isoflurane—Rash—Methotrexate—lymphatic system cancer	0.0025	0.0025	CcSEcCtD
Isoflurane—Dermatitis—Methotrexate—lymphatic system cancer	0.0025	0.0025	CcSEcCtD
Isoflurane—Nausea—Methotrexate—lymphatic system cancer	0.00236	0.00236	CcSEcCtD
